Meridian Bioscience, Inc. (VIVO)


-0.16 (-0.49%)
Strong Buy
Symbol VIVO
Price $32.59
Beta 0.276
Volume Avg. 0.80M
Market Cap 1.426B
Shares () -
52 Week Range 17.2-34.38
1y Target Est -
DCF Unlevered VIVO DCF ->
DCF Levered VIVO LDCF ->
ROE 12.28% Buy
ROA 9.32% Neutral
Operating Margin -
Debt / Equity 27.46% Neutral
P/E 33.26 Strong Buy
P/B 3.89 Strong Buy


Consensus EPS

Upgrades & Downgrades

Latest VIVO news

Mr. John Kenny
Diagnostics & Research
NASDAQ Global Select

Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, including real-time PCR amplification under the Revogene brand; isothermal DNA amplification under the Alethia brand; lateral flow immunoassay using fluorescent chemistry under the Curian brand; rapid immunoassay under the ImmunoCard and ImmunoCard STAT! brands; enzyme-linked immunoassays under the PREMIER brand; anodic stripping voltammetry under the LeadCare brands; and urea breath testing for H. pylori under the BreathID and BreathTek brand. This segment also offers respiratory illness assays, such as tests Group A strep, mycoplasma pneumonia, influenza, and pertussis; and blood chemistry products for LeadCare test kits for the detection of lead in blood. It sells products through direct sales force and independent distributors to acute care hospitals, reference laboratories, outpatient clinics, and physician office laboratories. The Life Science segment offers bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, and bioresearch reagents used by in vitro diagnostic manufacturers, as well as researchers in immunological and molecular tests for human, animal, plant, and environmental applications. Meridian Bioscience, Inc. was incorporated in 1976 and is headquartered in Cincinnati, Ohio.